FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067375 [Registered on: 15/05/2024] Trial Registered Prospectively
Last Modified On: 15/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Curative]  
Study Design  Single Arm Study 
Public Title of Study   Effect of virechana Karma With trivrit Churna in Vatarakta w.s.r to Gout. 
Scientific Title of Study   A clinical study on the effect of Virechan karma with Trivrit churn in the management of Vatrakta w.s.r to Gout. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Aditya Prasad Satapathy 
Designation  MD( Ay.) Scholar(Panchakarma) 
Affiliation  Government Ayurvedic college & Hospital,near budhmurti,Kadamkuan,patna. 
Address  Department of Panchakarma Government Ayurvedic college & Hospital, near budhmurti,Kadamkuan,patna.

Patna
BIHAR
800003
India 
Phone  7008146525  
Fax  -  
Email  adityasatapathy10@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Akhilesh Prasad Singh 
Designation  H.O.D, Associate Professor Department of Panchakarma 
Affiliation  Government Ayurvedic college & Hospital,near budhmurti,Kadamkuan,patna. 
Address  Department of Panchakarma Government Ayurvedic college & Hospital,near Budhmurti,Kadamkuan,patna.

Patna
BIHAR
800003
India 
Phone  8002680973  
Fax  -  
Email  drapsinghpatna@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Akhilesh Prasad Singh 
Designation  H.O.D, Associate Professor Department of Panchakarma 
Affiliation  Government Ayurvedic college & Hospital,near budhmurti,Kadamkuan,patna. 
Address  Department of Panchakarma Government Ayurvedic college & Hospital,near budhmurti,Kadamkuan,patna.

Patna
BIHAR
800003
India 
Phone  8002680973  
Fax  -  
Email  drapsinghpatna@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurvedic college & Hospital,near budhmurti,Kadamkuan,patna,Bihar. 
 
Primary Sponsor  
Name  DrAditya Prasad Satapathy 
Address  Department of Panchakarma Government Ayurvedic college & Hospital,near Budhmurti,Kadamkuan,patna. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aditya Prasad Satapathy  Government Ayurvedic College and Hospital.  OPD no -11, Department of Panchakarma, Kadamkuan,near budhmurti,Patna,800003
Patna
BIHAR 
7008146525
-
adityasatapathy10@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee (IEC)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M109||Gout, unspecified. Ayurveda Condition: VATARAKTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-virecana-karma, विरेचन-कर्म (Procedure Reference: charak samhita chikitsa sthan 29/41, Procedure details: As pre operative procedure post deepan and pachana, shodhan snehpana will be done for 5 days followed by 3 days of rest along with bahya snehan and swedana and finally virechana karma on the 4th day.)
(1) Medicine Name: Trivrit churna, Reference: charak samhita chikitsa sthan 29/84, Route: Oral, Dosage Form: Churna/ Powder, Dose: 24(g), Frequency: od, Duration: 1 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients having Serum uric acid conc. more than 7.0mg/dl in male and more than 6.0 mg/dl in female. Patients having their age more than 18 years and below 70 years.
Patients having sign & symptoms of vatarakta (Gout).
All three essential symptoms with or without non-essential symptoms. Essential criteria:-
1. pain in affected joint.
2.swelling in the affected joint.
3.loss of tactile sensation. Non-essential criteria:-
1.redness in affected joint.
2.itching in affected joint.
3.burning sensation over joint.
4.discoloration of skin of affected joint.  
 
ExclusionCriteria 
Details  Patients of age below 18 and above 70 years.
Patients having complications of vatarakta (upadrava) like, moorcha, hikka etc.
Patients having secreting tophus.
Patients associated with HIV, Hepatitis and also pregnant women.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The improvement in the patients will be assessed mainly on the basis of relief in the cardinal symptoms of disease. To access the effect of therapy subjectively, all the sign & symptoms will be relief in
1.pain in affected joint.
2.swelling in the affected joint.
3.laws of tactile sensation. upon their severity.  
55days 
 
Secondary Outcome  
Outcome  TimePoints 
The analysis of the values of the serum uric acid will be done before & after the treatment and during the follow up to compare the condition of affected joints.   55days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   27/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [adityasatapathy10@gmail.com].

  6. For how long will this data be available start date provided 25-04-2025 and end date provided 02-02-2030?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   This study is randomised open interventional prospective trail to study the effect of virechana karma by trivrit churna in the management of vatarakta with special reference to gout in a group of 30 patients. This study will be conducted in Government Ayurvedic College and Hospital,patna,Bihar in the department of Panchakarma. After 25 days of intervention two follow up will be done every 15 days for total duration of study i.e of 55 days 
Close